loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2013_287___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Palla Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PALLA PHARMA NORWAY AS Kragerø NO (1)

    filter

    01 Codeine phosphate hemihydrate, Process II (1)

    filter

    01 Australia (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    PALLA PHARMA NORWAY AS Kragerø NO

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Australia
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Codeine phosphate hemihydrate, Process II

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2013-287 - Rev 01
      Valid
      Chemical
      2021-03-04
      74
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-287 - Rev 01 of Palla Pharma Norway As Kragerø No

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-287 - Rev 01 of Palla Pharma Norway As Kragerø No 1

      20

      Palla Pharma Norway As Kragerø No, based in Australia, is a pharmaceutical company.

      One of their significant offerings is Codeine phosphate hemihydrate, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-287 - Rev 01

      This Chemical Type CEP, issued on March 04, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 74 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY